Hosted on MSN28d
Artelo Biosciences reports promising nonclinical CBD study
At the International Medical (TASE:PMCN) Cannabis Conference (IMCCB-25) in Bern, Switzerland ... studies showed comparable or greater levels of CBD and metabolite exposure than Epidiolex.
KELOLAND News1mon
Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland
a proprietary cocrystal composed of cannabidiol (CBD) and tetramethylpyrazine (TMP), at the International Medical Cannabis Conference (IMCCB-25) held at the University of Bern, Switzerland ...
Morningstar1mon
Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland
Morningstar brands and products Company Portfolio ...
Taiwan News1mon
Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland
a proprietary cocrystal composed of cannabidiol (CBD) and tetramethylpyrazine (TMP), at the International Medical Cannabis Conference (IMCCB-25) held at the University of Bern, Switzerland February 13 ...